Clinical Trial Detail

NCT ID NCT02564900
Title Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Daiichi Sankyo Co., Ltd.
Indications

gastroesophageal junction adenocarcinoma

breast cancer

Advanced Solid Tumor

gastric adenocarcinoma

Therapies

Trastuzumab deruxtecan

Age Groups: adult senior

Additional content available in CKB BOOST